Rocket Pharmaceuticals
RCKT
$22.80
Share price
-2.90%
Change (1 day)
19.81%
Change (1 year)
Categories
Earnings for Rocket Pharmaceuticals (RCKT)
Earnings in 2023 (TTM): -$0.25 B
According to Rocket Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$0.25 B. In 2022 the company made an earning of -$0.23 B a decrease over its 2021 earnings that were of -$0.17 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Rocket Pharmaceuticals from 2014 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.25 B | 10.7% |
| 2022 | -$0.23 B | 31.23% |
| 2021 | -$0.17 B | 21.02% |
| 2020 | -$0.14 B | 80.79% |
| 2019 | -$77.27 M | 3.69% |
| 2018 | -$74.52 M | 323.4% |
| 2017 | -$17.6 M | -58.93% |
| 2016 | -$42.86 M | -36.96% |
| 2015 | -$67.99 M | 613.27% |
| 2014 | -$9.54 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -54.89% | 🇺🇸 USA |